Quarterly report pursuant to Section 13 or 15(d)

STOCK INCENTIVE PLAN

v3.8.0.1
STOCK INCENTIVE PLAN
9 Months Ended
Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK INCENTIVE PLAN
NOTE 12. STOCK INCENTIVE PLAN
 
Our Amended and Restated 1999 Stock Incentive Plan (the “Plan”) provides for grants of equity-based awards to employees, non-employee directors and officers, and advisors of the company (“Eligible Persons”). The Plan is designed to promote the interests of the company using equity investment interests to attract, motivate, and retain individuals.
 
A maximum of 5,000,000 shares of common stock are authorized under the Plan. All awards have restriction periods tied primarily to employment and/or service. The Plan allows for accelerated or continued vesting in certain circumstances as defined in the Plan including death, disability, a change in control, and termination or retirement. The Board of Directors, or a committee appointed by the Board, has discretion subject to limits defined in the Plan, to modify the terms of any outstanding award.
 
Under the Plan, the Board, or a committee appointed by the Board, may impose restrictions on the exercise of awards during pre-defined blackout periods. Insiders may participate in plans established pursuant to Rule 10b5-1 under the Exchange Act that allow them to exercise awards subject to pre-established criteria.
 
We recognize non-cash stock-based compensation expense based on the estimated fair value of awards in accordance with FASB ASC Topic 718 “Compensation—Stock Compensation.” Stock-based compensation expense fluctuates over time as a result of the vesting periods for outstanding awards and the number of awards that actually vest. We adopted ASU 2016-09, “Improvements to Employee Share-Based Payment Accounting” as of January 1, 2017. The adoption of this ASU did not materially impact our financial position, results of operations, or cash flows.
 
The following table reflects the components of stock-based compensation expense recognized in the Condensed Consolidated Statements of Operations for the three and nine month periods ended September 30, 2017 and 2016:
 
 
 
Three Months Ended
 
Nine Months Ended
 
 
 
September 30,
 
September 30,
 
 
 
2016
 
2017
 
2016
 
2017
 
 
 
(Dollars in thousands)
 
Stock option compensation expense included in corporate expenses
 
$
94
 
$
27
 
$
296
 
$
126
 
Restricted stock shares compensation expense included in corporate expenses
 
 
—
 
 
225
 
 
24
 
 
1,100
 
Stock option compensation expense included in broadcast operating expenses
 
 
19
 
 
7
 
 
67
 
 
41
 
Restricted stock shares compensation expense included in broadcast operating expenses
 
 
—
 
 
—
 
 
—
 
 
224
 
Stock option compensation expense included in digital media operating expenses
 
 
12
 
 
6
 
 
51
 
 
25
 
Restricted stock shares compensation expense included in digital media operating expenses
 
 
—
 
 
—
 
 
—
 
 
124
 
Stock option compensation expense included in publishing operating expenses
 
 
9
 
 
3
 
 
20
 
 
17
 
Restricted stock shares compensation expense included in publishing operating expenses
 
 
—
 
 
—
 
 
—
 
 
36
 
Total stock-based compensation expense, pre-tax
 
$
134
 
$
268
 
$
458
 
$
1,693
 
Tax benefit (expense) for stock-based compensation expense
 
 
(54)
 
 
(107)
 
 
(183)
 
 
(677)
 
Total stock-based compensation expense, net of tax
 
$
80
 
$
161
 
$
275
 
$
1,016
 
 
Stock Option and Restricted Stock Grants
 
Eligible employees may receive stock option awards annually with the number of shares and type of instrument generally determined by the employee’s salary grade and performance level. Incentive and non-qualified stock option awards allow the recipient to purchase shares of our common stock at a set price, not to be less than the closing market price on the date of award, for no consideration payable by the recipient. The related number of shares underlying the stock option is fixed at the time of the grant. Options generally vest over a four-year period with a maximum term of five years from the vesting date. In addition, certain management and professional level employees may receive stock option awards upon the commencement of employment.
 
The Plan also allows for awards of restricted stock, which have been granted periodically to non-employee directors of the company. Awards granted to non-employee directors are made in exchange for their services to the company as directors and therefore, the guidance in FASB ASC Topic 505-50 “Equity Based Payments to Non Employees” is not applicable. Restricted stock awards contain transfer restrictions under which they cannot be sold, pledged, transferred or assigned until the period specified in the award, generally from one to five years. Restricted stock awards are independent of option grants and are granted at no cost to the recipient other than applicable taxes owed by the recipient. The awards are considered issued and outstanding from the vest date of grant.
 
The fair value of each award is estimated as of the date of the grant using the Black-Scholes valuation model. The expected volatility reflects the consideration of the historical volatility of our common stock as determined by the closing price over a six to ten year term commensurate with the expected term of the award. Expected dividends reflect the amount of quarterly distributions authorized and declared on our Class A and Class B common stock as of the grant date. The expected term of the awards are based on evaluations of historical and expected future employee exercise behavior. The risk-free interest rates for periods within the expected term of the award are based on the U.S. Treasury yield curve in effect during the period the options were granted. We have used historical data to estimate future forfeiture rates to apply against the gross amount of compensation expense determined using the valuation model. These estimates have approximated our actual forfeiture rates.
 
There were no stock options granted during the nine month period ended September 30, 2017. The weighted-average assumptions used to estimate the fair value of the stock options using the Black-Scholes valuation model were as follows for the three and nine month periods ended September 30, 2016:
 
 
 
Three Months Ended
 
Nine Months Ended
 
 
 
September 30, 2016
 
September 30, 2016
 
Expected volatility
 
n/a
 
 
47.03
%
Expected dividends
 
n/a
 
 
5.36
%
Expected term (in years)
 
n/a
 
 
7.4
 
Risk-free interest rate
 
n/a
 
 
1.64
%
 
Activity with respect to the company’s option awards during the nine month period ended September 30, 2017 is as follows:
 
 
 
 
 
 
 
 
 
 
Weighted Average
 
Aggregate
 
 
 
 
 
Weighted Average
 
Weighted Average
 
 
Remaining Contractual
 
Intrinsic
 
Options
 
Shares
 
Exercise Price
 
Grant Date Fair Value
 
 
Term
 
Value
 
 
 
(Dollars in thousands, except weighted average exercise price and weighted average grant date fair value)
 
Outstanding at January 1, 2017
 
 
1,720,000
 
$
5.12
 
$
2.89
 
 
4.5 years
 
$
2,428
 
Granted
 
 
—
 
 
—
 
 
—
 
 
 
 
 
 
 
Exercised
 
 
(122,413)
 
 
4.09
 
 
2.04
 
 
 
 
 
 
 
Forfeited or expired
 
 
(143,125)
 
 
5.85
 
 
2.99
 
 
 
 
 
 
 
Outstanding at September 30, 2017
 
 
1,454,462
 
$
5.18
 
$
2.95
 
 
3.9 years
 
$
2,292
 
Exercisable at September 30, 2017
 
 
954,959
 
$
5.63
 
$
3.76
 
 
2.9 years
 
$
1,146
 
Expected to Vest
 
 
474,278
 
$
5.19
 
$
2.97
 
 
3.9 years
 
$
1,115
 
 
The aggregate intrinsic value represents the difference between the company’s closing stock price on September 30, 2017 of $6.60 and the option exercise price of the shares for stock options that were in the money, multiplied by the number of shares underlying such options. The total fair value of options vested during the nine month periods ended September 30, 2017 and 2016 was $0.9 million and $1.1 million, respectively.
 
As of September 30, 2017, there was $0.2 million of total unrecognized compensation cost related to non-vested stock option awards. This cost is expected to be recognized over a weighted-average period of 1.6 years.
 
On August 9, 2017, a restricted stock award of 33,066 shares was granted to an executive that vested immediately. The fair value of the restricted stock award was measured based on the grant date market price of our common shares and expensed as of the vesting date. The restricted stock award contains transfer restrictions under which they cannot be sold, pledged, transferred or assigned until three months from vesting date. The recipient of this restricted stock award is entitled to all of the rights of absolute ownership of the restricted stock from the date of grant, including the right to vote the shares and to receive dividends. Restricted stock awards are independent of option grants and are granted at no cost to the recipient other than applicable taxes owed by the recipient. The award is considered issued and outstanding from the vest date of grant.
 
On February 24, 2017, a restricted stock award of 178,592 shares was granted to certain members of management that vested immediately. The fair value of each restricted stock award was measured based on the grant date market price of our common shares and expensed as of the vesting date. These restricted stock awards contained transfer restrictions under which they could not be sold, pledged, transferred or assigned until three months from vesting date. Recipients of these restricted stock awards were entitled to all of the rights of absolute ownership of the restricted stock from the date of grant including the right to vote the shares and to receive dividends. Restricted stock awards are independent of option grants and are granted at no cost to the recipient other than applicable taxes owed by the recipient. The awards were considered issued and outstanding from the vest date of grant.
 
Activity with respect to the company’s restricted stock awards during the nine month period ended September 30, 2017 is as follows:
 
 
 
 
 
Weighted Average
 
 
Weighted Average Remaining
 
Aggregate
 
Restricted Stock Awards
 
Shares
 
Grant Date Fair Value
 
 
Contractual Term
 
Intrinsic Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Dollars in thousands, except weighted average exercise price and weighted average grant date fair value)
 
Outstanding at January 1, 2017
 
 
—
 
$
—
 
 
—
 
$
—
 
Granted
 
 
211,658
 
 
7.01
 
 
0.2 years
 
 
1,484
 
Lapse of restrictions
 
 
(178,592)
 
 
7.05
 
 
—
 
 
1,259
 
Forfeited
 
 
—
 
 
—
 
 
—
 
 
—
 
Outstanding at September 30, 2017
 
 
33,066
 
$
6.80
 
 
0.2 years
 
$
225